Click here for Prevenar 13® (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Prevenar 13 is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in adults ≥ 18 years of age and the elderly.1
* vs placebo.4 Data from a randomised, placebo-controlled, double-blind trial demonstrated the efficacy of Prevenar 13 vs placebo in the prevention of a first episode of confirmed vaccine-type community-acquired pneumococcal pneumonia in adults aged > 65 years of age.4 Post-hoc analysis showed that the efficacy of Prevenar 13 vs placebo persisted throughout the 4-year trial.4
Pneumococcal pneumonia can strike people of any age.3 However, many factors put adults at increased risk of pneumococcal infections, including pneumococcal pneumonia, making them potential candidates for vaccination.3,5-11
So, there are a lot of occasions where you can help protect your patients with Prevenar 13 vaccination.12
**Risk data above is for people aged 50-64. People aged 18-49 had lower ratios and ≥ 65 had higher ratios.
Access E-learning modules for our Vaccine brands
E learning modules
1) Private vaccination service
2) Prevenar 13 Quick
Order your patient materials to support your services
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020